miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy

Figure 1

miR-651-3p was downregulated in HCC tissues and drug-resistant HCC cells. (a) The relative expression levels of miR-651-3p in normal and tumor tissues measured by qRT-PCR. (b) The expression levels of miR-651-3p in HepG2 cells and resistant HepG2 (R-HepG2) were measured by qRT-PCR; (c) The expression levels of miR-651-3p in Hub7 cells and resistant Hub7 (R-Hub7) measured by qRT-PCR.

(a)

(b)

(c)